Amgen Stock Price - AMGN

225.865
0.195 (0.09%)
225.67
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Amgen Inc AMGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
4.79 2.17% 225.67 218.20 225.9499 219.77 220.88 18:07:22
Bid Price Ask Price Spread Spread % News
225.44 226.00 0.56 0.25% - 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
49,417 3,714,631 $ 222.98 $ 828,291,615 2,888,718 172.16 - 247.9999
Last Trade Time Type Quantity Stock Price Currency
18:16:14 1 $ 225.865 USD

Amgen Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 132.75B 588.25M 585.23M $ 23.36B $ 7.48B 12.89 17.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 5.80 2.57% - -

more financials information »

Amgen News

Date Time Source News Article
6/05/202016:00PR Newswire (US)Amgen To Present At The Goldman Sachs 41st Annual Global..
5/29/202008:00PR Newswire (US)Amgen Presents New AMG 510 Clinical Data Across Multiple..
5/28/202017:00PR Newswire (US)Amgen To Present At The Jefferies 2020 Virtual Healthcare..
5/27/202010:00Dow Jones NewsFresenius Kabi: FDA Accepts BLA for Neulasta Biosimilar
5/26/202017:00PR Newswire (US)Amgen To Webcast Investor Meeting At 56th Annual Meeting Of..
5/20/202019:00PR Newswire (US)Amgen Announces Voting Results Of Annual Meeting Of..
5/20/202017:13Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AMGN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week225.00230.57218.20224.492,911,4270.670.3%
1 Month234.95244.50217.465229.702,852,143-9.28-3.95%
3 Months189.76245.00177.05217.773,246,22335.9118.92%
6 Months233.69247.9999177.05220.542,832,117-8.02-3.43%
1 Year175.65247.9999172.16209.692,707,67350.0228.48%
3 Years160.29247.9999158.27191.812,929,01765.3840.79%
5 Years158.50247.9999130.08177.343,019,08067.1742.38%

Amgen Description

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).
Your Recent History
NASDAQ
AMGN
Amgen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200605 22:41:55